Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reaw...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
Heavey
Heavey May. 16 at 5:42 AM
$ABUS seeking a deposition from Albert Bourla, Pfizer CEO, the big wig.
0 · Reply
hopeful2bright
hopeful2bright May. 15 at 11:29 PM
$ABUS Haven’t seen anything like it in my investing career. With ROIV 38 million share position and recent Nasdaq that Heavey has shown, 95% REPEAT 95% OF SHARES ARE OWNED BY BIG BOYS. Share price hasn’t moved. I will hold onto ALL my shares and playing this one out to the end. Unreal, 95%. Good luck to all longs that are holding on!!
1 · Reply
Heavey
Heavey May. 15 at 10:59 PM
$ABUS tute holdings 76%! Good enough for me.
0 · Reply
Shortsales
Shortsales May. 15 at 10:05 PM
$ABUS Two Seas Capital just disclosed a 9.4% stake in Arbutus Biopharma — that’s 18.56 million shares 🚀 They added roughly 6 million shares since their last filing, increasing their ownership significantly. The filing was submitted today 📈
2 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 15 at 10:04 PM
$ABUS Thus ends another quarterly report where the tutes were practically stealing from the dim-witted, no attention span, penny-trading retail trader.
0 · Reply
Blueviking
Blueviking May. 15 at 9:34 PM
$ABUS https://investor.arbutusbio.com/node/19556/html Two Seas are rocking. I will follow!
2 · Reply
Heavey
Heavey May. 15 at 8:02 PM
$ABUS FYI all, today was the 3rd Friday of the month. No surprises here.
0 · Reply
SpaceCityKid
SpaceCityKid May. 15 at 7:41 PM
$ABUS ROIV is on the verge of a major breakout. That should bode well for us.
0 · Reply
SpaceCityKid
SpaceCityKid May. 15 at 4:37 PM
$ABUS Selling volume is drying up. A little over a week until the shareholder meeting. It feels like all the ducks are finally getting in a row.
0 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 15 at 3:29 PM
$ABUS Nasdaq site has Barclays plc adding almost 4 million shares last quarter...can't find it listed on Fintel?
0 · Reply
Latest News on ABUS
Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

2026-03-04T16:55:47.000Z - 2 months ago

Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

MRNA


Unusually active option classes on open March 4th

2026-03-04T14:40:55.000Z - 2 months ago

Unusually active option classes on open March 4th

AAOI ANF DVN F NU PLUG POET


Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

2025-11-13T12:41:19.000Z - 6 months ago

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus Biopharma Transcript: Status Update

Dec 3, 2024, 11:00 AM EST - 1 year ago

Arbutus Biopharma Transcript: Status Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus Biopharma Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q3 2024


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Biopharma Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q2 2024


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 2 years ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 2 years ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


Arbutus Biopharma Earnings Call Transcript: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q1 2024


Arbutus Biopharma Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q4 2023


Arbutus Biopharma Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q3 2023


Arbutus Biopharma Earnings Call Transcript: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2023


Heavey
Heavey May. 16 at 5:42 AM
$ABUS seeking a deposition from Albert Bourla, Pfizer CEO, the big wig.
0 · Reply
hopeful2bright
hopeful2bright May. 15 at 11:29 PM
$ABUS Haven’t seen anything like it in my investing career. With ROIV 38 million share position and recent Nasdaq that Heavey has shown, 95% REPEAT 95% OF SHARES ARE OWNED BY BIG BOYS. Share price hasn’t moved. I will hold onto ALL my shares and playing this one out to the end. Unreal, 95%. Good luck to all longs that are holding on!!
1 · Reply
Heavey
Heavey May. 15 at 10:59 PM
$ABUS tute holdings 76%! Good enough for me.
0 · Reply
Shortsales
Shortsales May. 15 at 10:05 PM
$ABUS Two Seas Capital just disclosed a 9.4% stake in Arbutus Biopharma — that’s 18.56 million shares 🚀 They added roughly 6 million shares since their last filing, increasing their ownership significantly. The filing was submitted today 📈
2 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 15 at 10:04 PM
$ABUS Thus ends another quarterly report where the tutes were practically stealing from the dim-witted, no attention span, penny-trading retail trader.
0 · Reply
Blueviking
Blueviking May. 15 at 9:34 PM
$ABUS https://investor.arbutusbio.com/node/19556/html Two Seas are rocking. I will follow!
2 · Reply
Heavey
Heavey May. 15 at 8:02 PM
$ABUS FYI all, today was the 3rd Friday of the month. No surprises here.
0 · Reply
SpaceCityKid
SpaceCityKid May. 15 at 7:41 PM
$ABUS ROIV is on the verge of a major breakout. That should bode well for us.
0 · Reply
SpaceCityKid
SpaceCityKid May. 15 at 4:37 PM
$ABUS Selling volume is drying up. A little over a week until the shareholder meeting. It feels like all the ducks are finally getting in a row.
0 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 15 at 3:29 PM
$ABUS Nasdaq site has Barclays plc adding almost 4 million shares last quarter...can't find it listed on Fintel?
0 · Reply
renoH4
renoH4 May. 15 at 2:59 PM
$ABUS was Tekmira in 2015 During the major Ebola outbreak in West Africa in 2014, the company’s stock experienced dramatic price surges. The reason was that Tekmira was developing an experimental Ebola treatment called TKM-Ebola. As the crisis escalated and the first Ebola cases were reported in the United States, investors heavily speculated that the company could benefit from emergency approvals or government contracts.
2 · Reply
renoH4
renoH4 May. 15 at 2:51 PM
$ABUS ..EBOLA outbreak! Remember - many years ago such an outbreak was the reason for a extrem share price jump. Arbutus was in the Focus for a medicin.
0 · Reply
NoBSPls
NoBSPls May. 15 at 2:28 PM
$ABUS It seems like the complicated ownership of ABUS (ROIV/Genevant) make a PFE B/O more difficult. ROIV doesn’t have that problem plus they have an all to willing BOD 😂
0 · Reply
mj6534
mj6534 May. 14 at 10:04 PM
0 · Reply
Grtgooglymoogly
Grtgooglymoogly May. 14 at 5:42 PM
$ABUS No upside? If you believe the market has already priced in Abus getting their full share of the first settlement that's about 3 dollars and 70 cents of the current price. The bad news is that in this the market doesnt believe in the HepB assets--60 cents per share in value. ANYTHING positive in hepb will be upside.....Now double that 3.70 and get 7.40 in upside value for a 4.5 billion Pfizer settlement, and add it to the 3.70 = an 11 dollar stock without hepb at all....the numbers may be off a little, but who the f cares with a stock price in double digits at this point.
1 · Reply
hopeful2bright
hopeful2bright May. 14 at 2:45 PM
$ABUS Pure speculation on my part but I see them using additional shares for whomever moves HepB forward for Phase IIb. If good/great results, PFE settles and completes Phase III. Going to take more time, but ABUS will be many multiples of current price with Phase IIb success. Maybe whoever buys them takes on risk of Phase IIb but multiple of stock price obviously will be less. Seems to me its PFE with ROIV next in line for potential acquirer.
1 · Reply
Millionaire30x
Millionaire30x May. 14 at 2:01 PM
$ABUS honest question. Does anyone have any real money in this shit stock. I’m dying to know. Btw. Real money to me is 25k plus.
9 · Reply
Nile1
Nile1 May. 14 at 11:26 AM
$ABUS we will see the actual reaction in two to three days post earnings. Usually the first day is just a noise from retailers, but the real reaction from institutions will follow in the coming 2 to 3 days, that’s just my opinion,
1 · Reply
StockosaurusTex
StockosaurusTex May. 14 at 11:17 AM
0 · Reply
mj6534
mj6534 May. 13 at 7:36 PM
$ABUS i’m glad this panned out how we all expected lol to be fair. I did not have high hopes with my posts. I know how this charade works at this point. 
0 · Reply
StockosaurusTex
StockosaurusTex May. 13 at 5:18 PM
0 · Reply
LM_Johanssen
LM_Johanssen May. 13 at 5:03 PM
$ABUS What are they waiting for
2 · Reply